Advertisement
U.S. markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
10.72-0.01 (-0.14%)
At close: 04:00PM EDT
10.67 -0.05 (-0.47%)
After hours: 07:20PM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
832.01
832.01
10,262
1,775
7,411
Operating Expense
134,259
134,259
277,836
302,993
131,493
Operating Income
-133,427
-133,427
-267,574
-301,218
-124,082
Net Non Operating Interest Income Expense
6,911
6,911
3,528
1,427
-5,391
Other Income Expense
-8,601
-8,601
-13,607
-3,433
-33,418
Pretax Income
-135,117
-135,117
-277,653
-303,224
-162,890
Tax Provision
-
-
-
0
0
Earnings from Equity Interest Net of Tax
0
0
-2,165
-434.387
-4,585
Net Income Common Stockholders
-135,117
-135,117
-279,818
-303,659
-166,411
Diluted NI Available to Com Stockholders
-135,117
-135,117
-279,818
-303,659
-166,411
Basic EPS
-7.56
-6.09
-14.07
-17.45
-12.84
Diluted EPS
-7.56
-6.09
-14.07
-17.45
-12.84
Basic Average Shares
21,711
22,174
19,885
17,402
12,927
Diluted Average Shares
21,711
22,174
19,885
17,402
12,927
Total Operating Income as Reported
-143,940
-143,940
-267,574
-301,218
-124,082
Total Expenses
134,259
134,259
277,836
302,993
131,493
Net Income from Continuing & Discontinued Operation
-135,117
-135,117
-279,818
-303,659
-166,411
Normalized Income
-130,455
-130,455
-271,972
-300,436
-97,142
Interest Income
8,133
8,133
4,782
3,363
3,312
Interest Expense
1,223
1,223
1,254
1,936
8,702
Net Interest Income
6,911
6,911
3,528
1,427
-5,391
EBIT
-133,895
-133,895
-276,399
-301,288
-154,188
EBITDA
-130,391
-130,391
-270,903
-296,557
-149,560
Reconciled Depreciation
3,504
3,504
5,496
4,731
4,628
Net Income from Continuing Operation Net Minority Interest
-135,117
-135,117
-279,818
-303,659
-166,411
Total Unusual Items Excluding Goodwill
-4,663
-4,663
-7,846
-3,223
-69,269
Total Unusual Items
-4,663
-4,663
-7,846
-3,223
-69,269
Normalized EBITDA
-125,728
-125,728
-263,057
-293,334
-80,291
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0